Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pierre, L. N.
Right arrow Articles by Katusic, Z. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pierre, L. N.
Right arrow Articles by Katusic, Z. S.
Related Collections
Right arrow Acute Stroke Syndromes
Right arrow Other imaging
Right arrow Other Stroke Treatment - Medical

(Stroke. 1999;30:638-643.)
© 1999 American Heart Association, Inc.


Original Contributions

Blockade and Reversal of Endothelin-Induced Constriction in Pial Arteries From Human Brain

Lisa N. Pierre, PhD Anthony P. Davenport, PhD

From the Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.

Correspondence to Dr A.P. Davenport, Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. E-mail apd10{at}medschl.cam.ac.uk

Background and Purpose—Substantial evidence now implicates endothelin (ET) in the pathophysiology of cerebrovascular disorders such as the delayed vasospasm associated with subarachnoid hemorrhage and ischemic stroke. We investigated the ET receptor subtypes mediating vasoconstriction in human pial arteries.

Methods—ET receptors on human pial and intracerebral arteries were visualized with the use of autoradiography, and the subtypes mediating vasoconstriction were identified by means of wire myography.

Results—ET-1 was more potent than ET-3 as a vasoconstrictor, indicating an ETA-mediated effect. Similarly, the selective ETB agonist sarafotoxin S6c had no effect on contractile action at concentrations up to 30 nmol/L. The nonpeptide ETA receptor antagonist PD156707 (3 to 30 nmol/L) caused a parallel rightward shift of the ET-1–induced response, yielding a pA2 of 9.2. Consistent with these results, PD156707 (30 nmol/L) fully reversed an established constriction in pial arteries induced by 1 nmol/L ET-1, while the selective ETB receptor antagonist BQ788 (1 µmol/L) had little effect. The calcium channel blocker nimodipine (0.3 to 3 µmol/L) significantly attenuated the maximum response to ET-1 in a concentration-dependent manner without changing potency. In agreement with the functional data, specific binding of [125I]PD151242 to ETA receptors was localized to the smooth muscle layer of pial and intracerebral blood vessels. In contrast, little or no [125I]BQ3020 binding to ETB receptors was detected.

Conclusions—These data indicate an important role for ETA receptors in ET-1–induced constriction of human pial arteries and suggest that ETA receptor antagonists may provide additional dilatory benefit in cerebrovascular disorders associated with raised ET levels.

Editorial Comment

Zvonimir S. Katusic, MD, PhD, Guest Editor

Anesthesia Research, Mayo Clinic, Rochester, Minnesota




This article has been cited by other articles:


Home page
IOVSHome page
G. Michelson, S. Warntges, S. Leidig, J. Lotsch, and G. Geisslinger
Nimodipine plasma concentration and retinal blood flow in healthy subjects.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3479 - 3486.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Andresen, N. I. Shafi, and R. M. Bryan Jr.
Endothelial influences on cerebrovascular tone
J Appl Physiol, January 1, 2006; 100(1): 318 - 327.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Chuquet, K. Benchenane, J. Toutain, E. T. MacKenzie, S. Roussel, and O. Touzani
Selective Blockade of Endothelin-B Receptors Exacerbates Ischemic Brain Damage in the Rat
Stroke, December 1, 2002; 33(12): 3019 - 3025.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R Flemming, A Cheong, A M Dedman, and D J Beech
Discrete store-operated calcium influx into an intracellular compartment in rabbit arteriolar smooth muscle
J. Physiol., September 1, 2002; 543(2): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. C. Docherty, J. Kalmar-Nagy, M. Engelen, S. V. Koenen, M. Nijland, R. E. Kuc, A. P. Davenport, and P. W. Nathanielsz
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R261 - R268.
[Abstract] [Full Text] [PDF]